Advertisement
Organisation › Details
Orakl Oncology SAS
Orakl Oncology leverages tumor avatars that combine best-in-class biology with high-quality clinical and molecular data at scale. Our techbio platform enables oncology players to identify relevant targets and deliver better drugs, faster. As a spin-out from the Gustave Roussy Institute, the world's 3rd best cancer center, Orakl Oncology was co-founded by a team of seasoned experts with decades of international experience in cancer cell biology and engineering. *
Start | 2023-02-08 established (s-off) | |
Today | Speedinvest | |
Predecessor | Institut Gustave Roussy (IGR) | |
Industry | personalised medicine / precision medicine | |
Industry 2 | oncology | |
Person | Jaulin, Fanny (Orakl Oncology 202310 CEO + CSO + Co-Founder) | |
Person 2 | Pagès, Diane-Laure (Orakl Oncology 202310 COO + Co-Founder) | |
Region | Villejuif | |
Country | France | |
Street | 39 rue Camille Desmoulins | |
City | 94800 Villejuif | |
Address record changed: 2023-10-15 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Orakl Oncology SAS. (10/4/23). "Press Release: Orakl Oncology Raises €3 Million to Develop Its Techbio Platform for Precision Oncology". Paris. | ||
Record changed: 2024-03-30 |
Advertisement
More documents for Orakl Oncology SAS
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top